Toronto:RIV

Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

BioLumic partners with JWC and Helius Therapeutics for cannabis research program TORONTO, Jan. 9, 2020 /PRNewswire/ -- Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply it...

2020-01-08 20:00 5906